Guyasuta Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Guyasuta Investment Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-638	Closed	-$260K	–	244
2022 Q4	$260K	Hold	638	–	–	0.02%	199
2022 Q3	$208K	Hold	638	–	–	0.02%	214
2022 Q2	$224K	Buy	638 +230	+56%	+$93.8K	0.02%	241
2022 Q1	$223K	Hold	408	–	–	0.02%	260
2021 Q4	$269K	Hold	408	–	–	0.02%	240
2021 Q3	$254K	Hold	408	–	–	0.02%	239
2021 Q2	$258K	Hold	408	–	–	0.02%	233
2021 Q1	$200K	Hold	408	–	–	0.02%	242
2020 Q4	$204K	Buy	+408	New	+$183K	0.02%	228

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Guyasuta Investment Advisors's IDXX Position: Q1 2023 in Review

Guyasuta Investment Advisors sold out of Idexx Laboratories (IDXX) in Q1 2023, closing a stake of 638 shares — an estimated $260K sold.

Guyasuta Investment Advisors first reported a position in IDXX in Q4 2020 and held it in 9 quarters. The position peaked at $269K in Q4 2021. 1,055 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.

Guyasuta Investment Advisors reported no remaining Idexx Laboratories position as of Q1 2023 after selling out during the quarter.
Guyasuta Investment Advisors sold 638 Idexx Laboratories shares in Q1 2023, an estimated $260K.
Guyasuta Investment Advisors first reported a position in Idexx Laboratories in Q4 2020 and held it in 9 quarters.
Guyasuta Investment Advisors's Idexx Laboratories position peaked at $269K in Q4 2021.
1,055 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.

Based on Guyasuta Investment Advisors's 13F filing for Q1 2023, filed 28 Apr 2023.